Rituximab and hypogammaglobulinemia in the setting of ABO-incompatible kidney transplantation
Background: ABO-incompatible (ABOi) kidney transplantation can be achieved by desensitizing the recipient using apheresis plus rituximab-based immunosuppression. Objectives: We sought to ascertain the factors that contributed to low immunoglobulin levels at post-ABOi kidney transplantation. Patients...
Main Authors: | Hamza Naciri Bennani, Zhyiar Abdulraham, Bénédicte Puissant-Lubrano, Asma Allal, Lionel Rostaing |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2018-07-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/jnp-7-151.pdf |
Similar Items
-
Long-term outcomes after ABO-incompatible kidney transplantation; a single-center French study
by: Zhiyar Abdulrahman, et al.
Published: (2017-10-01) -
Successful pregnancy after in vitro fertilization in an ABO-incompatible kidney transplant recipient receiving rituximab: a case report
by: Akihiro Kosoku, et al.
Published: (2019-06-01) -
Current Perspectives in ABO-Incompatible Kidney Transplant
by: Maritati F, et al.
Published: (2022-05-01) -
Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation
by: Wei-Chen Lee, et al.
Published: (2021-12-01) -
Tonsillar granuloma associated with hypogammaglobulinemia
by: Aleksi Laajala, et al.
Published: (2020-05-01)